Cosmetic News is delighted to confirm that Syneron Candela will be sponsoring both The Aesthetic Awards and the Cosmetic News Expo, London. The awards will take place on December 7, 2013 while the Expo will be held on March 8-9, 2014. Syneron Candela is a global brand leader in technology innovation with a clear and focused strategy, driving the need for treatments to consumers and ensuring the footfall to your business is higher.

It has been the most hotly anticipated thing to happen in the aesthetics industry in years and now today the Keogh review has finally published its findings and outlined its recommendations for the future of the aesthetics market. 

The 67-page document could potentially have huge implications for the way medical aesthetics is practiced in the UK. The independent review into cosmetic interventions was published today and sets out how it would like to see the sector better regulated, practitioners better trained and people having proper redress if things go wrong. 

Chromogenex has introduced its third generation technology for the reduction of fat - i-LipoXcell. i-LipoXcell is FDA cleared for circumferential reduction and improvement in cellulite and incorporates four technologies for intelligent body fat analysis and measurement, laser diode fat reduction, IR Vacuum massage and radio-frequency skin tightening. i-LipoXcell is clinically proven, safe and treatment is comfortable, backed by leading physicians in worldwide multi-center studies.

i-Lipo incorporates patented technology to instantly measure body fat and provide detailed analysis including Basal Metabolic rate, body fat percentage and records in a patient data base reduction in body fat and overall improvement in patient health. Results can be printed out to show the positive results of incorporating i-Lipo laser into a lifestyle changing programme. Dr. J.P.Laura, Newport Beach, CA said, “i-Lipo is a true practice builder. It really works.” Steve Shapiro MD co-director of Gardens Dermatology and associate professor, at the University of Miami added, “I have been in practice for 20 years and have seen many different new technologies. The i-Lipo has been a “wow” in terms of results and no risk with high benefit.” 

Chromogenex will be holding a launch for i-LipoXcell on June 24, 2013 at The Royal Society of Medicine from 6-8pm.

Allergan, Inc. has welcomed many of the recommendations outlined in the Review of the Regulation of Cosmetic Interventions, chaired by Sir Bruce Keogh. In particular, Allergan is in favour of regulatory changes to classify all cosmetic implants including dermal fillers as medical devices and supports many of the other proposals such as calls to strengthen the existing European Medical Device Directive, plans to establish accredited training standards for health care professionals administering cosmetic implants, as well as steps to improve consultation and record keeping of patient treatments. 

Importantly, contrary to some of the points raised within the report regarding dermal filler regulation and manufacturing, Allergan estimates that over 96% of the dermal fillers sold in the UK are already classified as Medical Devices and are therefore controlled by European and UK legislation. Allergan’s JUVÉDERM® and SURGIDERM® brands of hyaluronic acid (HA) dermal fillers are categorised as Medical Devices, carrying the necessary CE Marks. These dermal fillers are backed by over 10 years of research and clinical experience including 19 Allergan-sponsored clinical trials (involving over 5,500 patients) and 15 investigator-initiated studies. Today, these products are available in more than 80 countries around the world and Allergan estimates that 16 million treatments have been given to date.

SkinCeuticals has launched a new sun protection product - Mineral Radiance UV Defense SPF50. The product contains a universal tint which works on all skin colours. It adds radiance to the skin tone and diminishes any white colouring of the skin that mineral sunscreens can sometimes leave. It is also ideal post-procedure for those who do not want to wear any make up after a treatment, but need to protect their skin and want something to improve its tone. It contains 100% mineral filters and offers high broad-spectrum UV protection. It also contains no parabens and is suitable for sensitive skin.

The British Association of Aesthetic Plastic Surgeons today welcomes ‘with relief’ the reported findings from Sir Bruce Keogh's inquiry into cosmetic surgery, in particular their recommendation for dermal fillers to be available via prescription only, as well as the need for more evidence-based research in cosmetic surgery.

Today, the Independent Healthcare Advisory Services (IHAS) welcomes the recommendations from the Department of Health Review of the Regulation of Cosmetic Interventions led by Professor Sir Bruce Keogh into regulating the cosmetic industry.

Sally Taber, Director of the Independent Healthcare Advisory Services and responsible for managing www.TreatmentsYouCanTrust.org.uk says, "The successful implementation of the recommendations on non-surgical procedures to ensure patient safety relies on two things. First, to end bad practice, the new qualification for cosmetic injectables must be underpinned by medical knowledge to ensure these medical treatments are administered safely. Second, it is important that these recommendations are executed swiftly to stop patients falling through the net. IHAS will be happy to utilise its existing framework and established industry guidelines to work constructively with the Government to expedite the process."

New Study Shows Sunscreen Plus Anti-Ageing Cosmetic Celfix DNA™ Youth Recovery™ Facial Serum Provide Significant Benefits to the Skin

A new study has revealled that cosmetic enzymes can help delay future signs of ageing. The March 2013 edition of the Journal of Drugs and Dermatology published renowned US Dermatologist James Spencer, MD, on the effects of sunscreen plus SilDerm-Celfix DNA™ Youth Recovery™ Facial Serum.

The study tested Celfix DNA™ on the arms of 19 patients, followed by a sunscreen twice a day for eight weeks. The results were groundbreaking, showing that Celfix DNA™ plus sunscreen are not only addressing damage caused by the sun, but also helping to delay future signs of ageing skin. “This research makes a strong argument for daily use of Celfix DNA™ and sunscreen for patients who want to delay the signs of ageing.”

BioActive Beauty has launched HydroPeptide SPF 30 Anti-Wrinkle Skin Enhancing UV Protection. Offering a broad spectrum protection from UVA/UVB rays and physical blockers Titanium Dioxide and Zinc Oxide, this revolutionary sunscreen contains Self Adjusting Spheres which blend perfectly to the color of your own skin tone– similarly to a tinted bronzer—enhancing your complexion and offering smooth, flawless coverage. 

Acai berry ,Green Tea, Medicinal Galanga and Aloe offer a rich blend of anti-inflammatories and powerful Antioxidant protection, shielding the skin from wrinkle forming free radicals. This sunscreen offers a lightweight feel and helps maintain a clearer complexion. 

SPF 30 also contains Calendula (wound healer), Cucumber (calming and Hydrating), and Chamomile (wound healer/calming) HydroPeptide® products are Paraben free. Phthalate free. Formulated for all skin types. 

mesoestetic® is extending its range of anti-ageing programmes with radiance DNA: a line designed to effectively address aesthetic concerns associated with stage IV skin ageing.

radiance DNA has been created to increase cell longevity, supporting the DNA repair and protection process with three steps:  cosmeceuticals for topical use; an intensive nutricosmetic treatment and a professional treatment. radiance DNA includes in its formula the innovative [meso]recovery complex®, a combination of active substances, especially selected for their cell DNA anti-oxidative, protecting and repair properties. Its exclusive technology is based on specific release biovectors,that are able to vehicle and release the complex of substances “unchanged” in the cell core, thereby ensuring an unprecedented efficacy. 

Sigmacon has launched the Lumenis LightSheer® DUET™, a highly effective, clinically proven system for high-speed permanent hair reduction. 

The LightSheer DUET’s high-speed hand piece has a spot size of 22 x 35 mm, enabling you to treat a back of a man in less than 10 minutes. The unique, vacuum-assisted technology enables a painless application and effective results with less fluence. The LightSheer DUET also includes the ET ChillTip hand-piece (9 x 9 mm) allowing comfortable treatment for areas requiring higher fluence or precision. LightSheer DUET offers the optimal combination between efficacy, safety and speed, making it the best investment for best results. In addition to permanent hair reduction and hair removal, the LightSheer DUET is cleared for treatment of pigmented lesions, vascular lesions, pseudofolliculitis barbae and leg veins.

A new non-surgical cosmetic clinic has opened at Spire Regency Hospital in Macclesfield supporting a campaign calling for non-medics to be banned from administering Botox.

Renew Medical Aesthetics will reassure patients undergoing non-surgical cosmetic treatments in an industry which has become flooded with High Street beauty salons offering treatments like Botox and dermal fillers with a lack of or very limited training. 

Cosmetic surgeon Dalvi Humzah has been appointed UK regional advisor for the West Midlands by the Royal College of Physicians and Surgeons of Glasgow. 

Working as part of a UK wide network of surgeons, Mr Humzah will promote the benefits of College membership, develop a local network of professional members and facilitate educational activities in the region to champion the highest standards of health care. Importantly, Mr Humzah, whose private practice Plastic and Dermatological Surgery (PDS) is based at Nuffield Health Cheltenham Hospital, Nuffield Health Wolverhampton, Solihull Bupa Wellness Centre and Ramsay Healthcare West Midlands Hospital – will work with local surgeons and physicians to encourage development and provide training across a wide range of medical and surgical specialities.

The launch of the second CEN enquiry on prEN 16372:2013 ‘Aesthetic surgery and aesthetic non-surgical medical services’ is now underway after a delay threatened to stall it.